13 May 2024 - PHARMAC is sharing what medicine applications will be considered at the Rare Disorders Advisory Committee meeting ...
25 April 2024 - Medivir announced today that its selective cathepsin K inhibitor, MIV-711, has been granted rare paediatric disease designation ...
8 April 2024 - If approved, elamipretide would become the first approved therapy for Barth syndrome. ...
29 February 2024 - On Rare Disease Day — a day when the international community raises awareness about rare conditions ...
29 February 2024 - PHARMAC understands that people living with rare disorders face many challenges, including access to health care ...
13 February 2024 - Over 8,000 patients 12 years of age and older with severe sickle cell disease or transfusion-dependent ...
7 February 2024 - Rhythm Pharmaceuticals today announced that the Italian Medicine Agency (AIFA) approved reimbursement (Gazzetta Ufficiale) for Imcivree (setmelanotide) ...
18 January 2024 - Since July 2023, there has been one in Germany for patients who suffer from acute myeloid leukaemia ...
10 January 2023 - Sebelipase alfa is recommended as an option for the treatment of patients with Wolman disease only if ...
8 January 2024 - We found that 491 novel orphan drugs were approved between 1990 and 2022. ...
13 December 2023 - NICE has published final evidence-based recommendations on the use of velmanase alfa (Lamzede) for treatment of ...
27 November 2023 - This cross-sectional study identified 25 “sole orphan” drugs qualifying for exemption from Medicare price negotiation. ...
13 November 2023 - PHARMAC is calling for applications for medicines to treat rare disorders. ...
3 November 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
31 October 2023 - FDA sets a PDUFA target action date of 30 April 2024. ...